Announced
Completed
Financials
Sources
Tags
Biotechnology
biotechnology research
Private Equity
Germany
Acquisition
Private
Majority
Friendly
Single Bidder
Completed
Cross Border
Synopsis
Fagron, a pharmaceutical compounding company, completed the acquisition of HiperScan, a provider of reliable raw material identification in pharmacies, from HTGF, a seed investor. Financial terms were not disclosed. "HTGF invested shortly after our foundation to help bring the scanning grating technology developed at the Fraunhofer IPMS in Dresden to market maturity. We then gradually evolved from a technology provider to an established industry solution provider that is now considered the gold standard in German pharmacies. As part of Fagron, we can now also contribute to accelerating the future of personalizing medicine," Alexander Wolter, HiperScan Managing Director.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.